Radient Technologies Inc V.RTI.H

Alternate Symbol(s): RDDTF

Radient Technologies Inc. is a science-based company. The Company is a commercial manufacturer of cannabinoid-based formulations, ingredients, and products. The principal activities of the Company and its subsidiaries are engaged in research, development, and commercialization of an efficient and environmentally responsible technology for the extraction, isolation, and purification of soluble products from a range of materials using microwave technology and a customized hydrocarbon extraction platform. The Company is focused on the formulation, manufacturing and launching of value-added cannabis products. It utilizes a proprietary extraction and downstream processing platform that recovers up to 99% of cannabinoids from the cannabis plant. It develops specialty products and ingredients that contain a range of cannabinoid and terpene profiles.

TSXV:RTI.H - Post by User

Radient Technologies Inc > radient

<< Previous

Bullboard Posts

Next >>

Comment by lscfaon Dec 25, 2020 10:42am

143 Views

Post# 32182533

RE:RE:radient

This 1982 patent supersedes Canopy's 2000 patent. Case closed.

https://patents.google.com/patent/US4554170A/en

lscfa wrote:

Canopy will lose. Supercritical Fluid Extraction has been around since the mid-1980s, well before the 2000 patent. Canopy paid $1.00 for the patent. What does that tell you?

For GW Pharmaceuticals to win, the company will have to demonstrate that its method, described in broad terms on its website, uses technology not claimed in Canopy’s patent—or that the technology that Canopy’s new patent claims were “known or obvious” in 2000, when the patent application was filed.

bbuddwisserr104 wrote: is getting help from canopy this should drive some other companies over to maps extraction with canopy sueing gw pharma over the use of co2 extraction which they have a patent as of today in the usa the patent expire in 1 1/2 years they got this co2 patent when they bought c3 cannabiboid in germany for 250m in 2019 valens medipharm boss etc are in trouble i would think how much is it going to cost to get a lic from cgc